Skip to main content

Table 3 Recurrent mutations in BRCA1/2 detected in 398 probands with epithelial ovarian cancer

From: BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population

Mutation/times detected

Unrelated probands (% of the total probands)

BRCA1

 c.4964_4982del19 - p.(Ser1655Tyrfs*16)/5

5 (1.3)

 c.5266dupC - p.(Gln1756Profs*74)/3

3 (0.8)

BRCA2

 c.5351dupA - p.(Asn1784Lysfs*3)/4

4 (1.0)

Total recurrent

12 (3.1)

Total recurrent (12)/total mutated (96) = 12.5%